Cipla Ltd. — Capital/Financing Update 2025

Feb 18, 2025

==> picture [84 x 30] intentionally omitted <==

18[th] February 2025

(1) BSE Limited Listing Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001 Scrip Code: 500087

(2) National Stock Exchange of India Limited Listing Department, Exchange Plaza, 5[th] floor, Plot no. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: CIPLA EQ

(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir / Madam,

Sub: Update on investment in Cipla Medpro South Africa Proprietary Limited

In compliance with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to our intimation dated 3[rd] February 2025, we hereby notify that the Company has completed investment of approx. ZAR 900 million in Cipla Medpro South Africa Proprietary Limited, South Africa, wholly owned subsidiary against allotment of 40,742,417 shares on 18[th] February 2025.

Please take the above information on record.

Yours faithfully,

For Cipla Limited RAJENDR Digitally signed by RAJENDRA A KUMAR KUMAR CHOPRA Date: 2025.02.18 CHOPRA 20:17:16 +05'30' Rajendra Chopra Company Secretary

Prepared by: Mandar Kurghode

Cipla Ltd. Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 41916000 F +91 22 41916120 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Numbe r L24239MH1935PLC002380